Chemours (CC) Operating Leases (2015 - 2026)

Chemours' Operating Leases history runs 10 years deep, the most recent figure standing at $192.0 million for Q1 2026.

• On a quarterly basis, Operating Leases fell 7.69% year-over-year to $192.0 million in Q1 2026; TTM through Mar 2026 was $192.0 million, a 7.69% decrease from a year earlier, with the FY2025 full-year figure at $191.0 million, down 3.54% from the prior year.
• Operating Leases grew to $192.0 million in Q1 2026 per CC's latest filing, from $191.0 million in the prior quarter.
• Across five years, Operating Leases topped out at $208.0 million in Q4 2023 and bottomed at $178.0 million in Q2 2022.
• The 5-year median for Operating Leases is $196.0 million (2023), against an average of $196.1 million.
• Across the five-year window, Operating Leases grew 10.61% in 2022 and fell 7.69% in 2026, its largest moves.
• Year by year, Operating Leases stood at $198.0 million in 2022, then grew by 5.05% to $208.0 million in 2023, then declined by 4.81% to $198.0 million in 2024, then fell by 3.54% to $191.0 million in 2025, then climbed by 0.52% to $192.0 million in 2026.
• Per Business Quant, the three latest CC Operating Leases figures stand at $192.0 million (Q1 2026), $191.0 million (Q4 2025), and $197.0 million (Q3 2025).